Authors: SIU LL ATTARDO G IZBICKA E LAWRENCE R CERNA C GOMEZ L DAVIDSON K FINKLE C MARSOLAIS C ROWINSKY EK VONHOFF DD

Citation: Ll. Siu et al., ACTIVITY OF (-)-2'-DEOXY-3'-OXACYTIDINE (BCH-4556) AGAINST HUMAN TUMOR COLONY-FORMING-UNITS, Annals of oncology, 9(8), 1998, pp. 885-891

Authors: STEPHENSON J BAKER SD AYLESWORTH C SIU L SIMMONS C SHARMA S SMITH L PROULX L MARSOLAIS C HUNT W VONHOFF D ROWINSKY E

Citation: J. Stephenson et al., A PHASE-I SAFETY AND PHARMACOKINETIC (PK) STUDY OF BCH-4556, A NOVEL L-NUCLEOSIDE ANTIMETABOLITE, ON A DAILY X 5 DAY EVERY 21-DAY SCHEDULE IN PATIENTS WITH SOLID NEOPLASMS, Annals of oncology, 9, 1998, pp. 596-596

Authors: BELANGER K MOORE M DIONNE J MCLEAN M PROULX L HUNT W MARSOLAIS C BAKER S WAINMAN N SEYMOUR L

Citation: K. Belanger et al., A PHASE-I STUDY OF THE NOVEL L-NUCLEOSIDE ANALOG BCH-4556 GIVEN EVERY21 DAYS, Annals of oncology, 9, 1998, pp. 601-601

Authors: DRAKE LA SHEAR NH ARLETTE JP CLOUTIER R DANBY FW ELEWSKI BE GARNISJONES S GIROUX JM GRATTON D GULLIVER W HULL P JONES HE JOURNET M KROL AL LEYDEN JJ MADDIN SC ROSS JB SAVIN RC SCHER RK SIBBALD GR TAWFIK NH ZAIAS N TOLPIN M EVANS S MARSOLAIS C CHIN T LIN TH MAHER T BIRNBAUM JE

Citation: La. Drake et al., ORAL TERBINAFINE IN THE TREATMENT OF TOENAIL ONYCHOMYCOSIS - NORTH-AMERICAN MULTICENTER TRIAL, Journal of the American Academy of Dermatology, 37(5), 1997, pp. 740-745